Making the News

 

Interview: Arjan Toor, CEO, Cigna Europe

HBI chats with Arjan Toor, CEO of Cigna Europe, about innovation in the insurance market against a backdrop of the pandemic, and a growing crisis in mental health.

German government pushing ahead with cannabis legalisation

The German health minister is pressing ahead with plans to legalise cannabis, despite concerns from some quarters that it could be challenged at the EU level, and unresolved questions about what the regulatory framework will look like. HBI speaks to legal and policy experts, and hears that medical cannabis producers have an early adopter advantage against potential rivals - and there are health implications if legislation passes.

Circle Health sponsors work visas for Ukrainian refugees fleeing war

For-profit UK hospital groups are working on their responses to the humanitarian crisis in Ukraine. Circle Health is to sponsor up to 500 work visas for Ukrainian refugees across its 54 sites in the UK. We find out more about the plan, and approach other large providers in the UK to find out what they are doing.

Pihlajalinna shares fall on results

Finnish outsourcing specialist Pihlajalinna posted some reasonable looking financials, on the face of it, for the full year to January 31, 2021 on Friday last week - so why have its shares dropped around 11% at the time of writing?

Ukrainian operators calm, but foreign investment could falter

The eyes of the world have been on Ukraine recently, as the risk of a Russian invasion ramps up. HBI speaks to operators, private equity, and pharma in the region to see if nerves are being held, or fraying, and how what happens in the next few weeks might hit for-profit healthcare in the region.

Labs could be next on property block

Life science properties that incorporate some laboratories in one form or another could be the next property boom says Piers Scrimshaw-Wright, who has just joined Knight Frank as Life Science and Innovation partner. So has anything been sold in Europe so far?

Find Us